Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

CLSD holding history

Clearside Biomedical, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLSD overviewAll 13F holders of CLSDFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CLSD by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−25,247−100.0%Sold outHolders
Q3 202525,247$100.2K<0.1%−7,859−23.7%ReducedConverted for a 1-for-15 splitHolders
Q2 2025496,589$397.3K<0.1%−57,923−10.4%ReducedHolders
Q1 2025554,512$509.0K<0.1%−167,277−23.2%ReducedHolders
Q4 2024721,789$685.7K<0.1%−23,100−3.1%ReducedHolders
Q3 2024744,889$946.0K<0.1%+162,200+27.8%AddedHolders
Q2 2024582,689$757.5K<0.1%+35,900+6.6%AddedHolders
Q1 2024546,789$837.0K<0.1%+162,100+42.1%AddedHolders
Q4 2023384,689$450.0K<0.1%+111,400+40.8%AddedHolders
Q3 2023273,289$238.0K<0.1%−63,400−18.8%ReducedHolders
Q2 2023336,689$377.0K<0.1%−122,700−26.7%ReducedHolders
Q1 2023459,389$478.0K<0.1%−128,003−21.8%ReducedHolders
Q4 2022587,392$658.0K<0.1%−71,097−10.8%ReducedHolders
Q3 2022658,489$744.0K<0.1%−149,300−18.5%ReducedHolders
Q2 2022807,789$1.19M<0.1%−57,162−6.6%ReducedHolders
Q1 2022864,951$1.98M<0.1%+435,734+101.5%AddedHolders
Q4 2021429,217$1.18M<0.1%+327,728+322.9%AddedHolders
Q3 2021101,489$609.0K<0.1%+30,900+43.8%AddedHolders
Q2 202170,589$344.0K<0.1%−493,910−87.5%ReducedHolders
Q1 2021564,499$1.39M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.